Ikarian Capital »

Alumis shares owned by Ikarian Capital

Quarter-by-quarter ownership of Alumis (ALMS) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Alumis

Tip: Access up to 7 years of quarterly data

All positions including Alumis held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alumis by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.1M 211k 9.76

More positions owned by Ikarian Capital

Cidara Therapeutics Com New (CDTX)
Spdr Series Trust State Street Spd Put Option (XBI)
Amgen (AMGN)
Terns Pharmaceuticals (TERN)
Abivax Sa Sponsored Ads (ABVX)
Harrow Health (HROW)
Rapt Therapeutics Com New (RAPT)
Cytokinetics Com New (CYTK)
Jazz Pharmaceuticals Call Call Option
Soleno Therapeutics (SLNO)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Maze Therapeatics (MAZE)
Omeros Corporation Call Option (OMER)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)

View all positions for Ikarian Capital

Top funds holding Alumis

AyurMaya Capital Management Company
Foresite Capital Management V
Samsara BioCapital
venBio Partners
BlackRock
Foresite Capital Management VI
Vanguard Group
Cormorant Asset Management
Saturn V Capital Management
Nextech Invest
Octagon Capital Advisors
MPM Oncology Impact Management
Sr One Capital Management
Baker Bros. Advisors
Geode Capital Management

View all funds holding Alumis